Advertisement

Topics

Editas Medicine Company Profile

10:27 EDT 23rd March 2019 | BioPortfolio

Editas Medicine is a transformative genome editing company founded by five world leaders in the fields of genome editing, protein engineering, and molecular and structural biology, with specific expertise in CRISPR/Cas9 and TALENs technologies. The company’s mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level. Editas Medicine was launched in November 2013 with funding from Flagship Ventures, Polaris Partners and Third Rock Ventures with participation from Partners Innovation Fund. For more information, visit www.editasmedicine.com.


News Articles [748 Associated News Articles listed on BioPortfolio]

Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101

Editas Medicine (Nasdaq:EDIT), a leading genome editing company, today announced the journal Nature Medicine published the comprehensive, pre-clinical data demonstrating the pharmacology and specifi...

Editas Medicine CEO Abruptly Resigns, Sends Stocks Plunging

Shares of Cambridge, Mass.-based Editas Medicine are down nearly 20 percent after Chief Executive Officer Katrine Bosley abruptly announced her decision to resign from her role at the company effectiv...

Editas Medicine Announces Chief Executive Officer Transition

Katrine Bosley to Step Down as President and CEO Director Cynthia Collins to Serve as Interim CEO Board of Directors Initiates Search for Permanent Successor CAMBRIDGE, Mass., Jan. 22, 2019 (GLOBE NEW...

Editas Wins FDA Approval for IND of CRISPR Treatment for LCA10

Editas Medicine said today it has won FDA approval of its IND application for its Leber Congenital Amaurosis type 10 (LCA10) candidate EDIT-101, enabling future clinical trials for what could emerge a...

Editas Medicine CEO steps down as company moves into product development stage

Shares of gene-editing companies were down Tuesday morning following the news, but analysts sought to reassure investors about Editas.

Gamida Cell and Editas Medicine Partner to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells

BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced an agreement with Editas Medicine, Inc., a leading genome editi...

Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial

Editas Medicine has the regulatory blessing to test its experimental gene-editing therapy in humans, and a $25 million check from its partner, Allergan, for hitting that milestone. But Editas will con...

Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More

In a week of big personnel moves, none was more surprising than Editas Medicine CEO Katrine Bosley’s departure. After guiding the CRISPR-Cas9 genome-editing startup from scientific breakthrough ...

PubMed Articles [1191 Associated PubMed Articles listed on BioPortfolio]

Medicine in Future and Advantages of Integrated Chinese and Western Medicine.

The history of medical development shows that oriental medicine, or traditional medicine, was born through medical practice during the times when science and technology were immature and underdevelope...

Supporting Family Medicine Research Capacity: The Critical Role and Current Contributions of US Family Medicine Organizations.

Family medicine is continuously advanced by a reinforcing research enterprise. In the United States, each national family medicine organization contributes to the discipline's research foundations. We...

ACEM involvement in a successful African emergency medicine programme.

In the past 5 years Botswana graduated its first home-grown doctors and emergency medicine specialists for the country. The postgraduate emergency medicine specialist training arrangement between Bots...

Address at the 60 Anniversary of Comrade MAO Ze-dong's Instruction on Western Medicine Doctors Learning Traditional Chinese Medicine.

Worldwide research productivity in nuclear medicine literature.

This study aimed to assess the quantity and quality of papers published in subspecialty nuclear medicine journals and provide an overview of worldwide research activity carried out in the field of nuc...

Clinical Trials [1471 Associated Clinical Trials listed on BioPortfolio]

Consultation Reasons in Family Medicine

The Tunisian society of family medicine STMF proposes to coordinate a national, observational, transversal and multicenter survey, at the consultations of general medicine / family medicin...

Virtual Lifestyle Medicine Comparative Effectiveness Research

This study evaluates the effectiveness of two online Lifestyle Medicine programs. Participants will be randomized by residence, urban vs. rural, into one of two Lifestyle Medicine programs...

Safety, Blood Levels and Effects of GW642444

GW642444 (the study medicine) is a new experimental medicine for treating asthma and chronic obstructive pulmonary disease (COPD). People with asthma and COPD suffer from breathlessness b...

Lifestyle Medicine for Depression

This study will examine the feasibility and efficacy of lifestyle medicine for the management of depression in Chinese adult population. The main components of lifestyle intervention typic...

Pilot Study of Vedic Medicine for Type 2 Diabetes

The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.

Companies [1069 Associated Companies listed on BioPortfolio]

Editas Medicine

Editas Medicine is a transformative genome editing company founded by five world leaders in the fields of genome editing, protein engineering, and molecular and structural biology...

Editas

Aeskulap Klinik

Where traditional medicine and complementary medicine combine to healThe Aeskulap Clinic combines conventional traditional medicine with complementary methods in the form of clinical holistic medicine...

Dr. Delany

Dr. Delany is a multiple board certified ( Internal Medicine, Cardiology, Critical Care, and Geriatrics) integrative medical physician who has been in the private practice of medicine for over 20 yea...

American Board of Obesity Medicine

The American Board of Obesity Medicine (ABOM) serves the public and the field of obesity medicine through the examination and certification of candidate physicians who seek recogn...

More Information about "Editas Medicine" on BioPortfolio

We have published hundreds of Editas Medicine news stories on BioPortfolio along with dozens of Editas Medicine Clinical Trials and PubMed Articles about Editas Medicine for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Editas Medicine Companies in our database. You can also find out about relevant Editas Medicine Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record